ROCKET PHARMACEUTICALS, INC. (RCKT) Deferred Tax Assets, Valuation Allowance USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rocket Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2014 to 2023.
  • Rocket Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $108 M, a 18.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $108 M +$17.2 M +18.9% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $91.3 M -$2.1 M -2.25% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $93.4 M -$7.22 M -7.18% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $101 M +$48.9 M +94.5% Dec 31, 2020 10-K 2023-02-28
Q4 2019 $51.7 M +$3.93 M +8.21% Dec 31, 2019 10-K 2022-02-28
Q4 2018 $47.8 M +$46 M +2622% Dec 31, 2018 10-K 2021-03-01
Q4 2017 $1.76 M +$1.27 M +264% Dec 31, 2017 10-K 2019-03-08
Q4 2016 $483 K -$50.7 M -99.1% Dec 31, 2016 10-K 2019-03-08
Q4 2015 $51.2 M +$6.31 M +14.1% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $44.9 M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.